LncRNA Information
ID EL0356 Name DRAIC Aliases N/A
Species Homo sapiens Chromosome 15 Start site 69463026
End site 69571440 Chain plus Exon NO. 5
Assembly Ensembl Release 89 Class lincRNA NCBI accession NR_026979
Ensembl ENSG00000245750 Sequence

Disease Method Sample Expression pattern Dysfunction type Description PMID Source
prostate cancer qPCR, Western blot etc. cell lines (VCap, PC3M-luc, LNCaP etc.) down-regulated N/A The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus. Prostate cancers persisting in patients after androgen deprivation therapy (ADT) select for decreased DRAIC expression, and higher levels of DRAIC in prostate cancer are associated with longer disease-free survival (DFS). DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma, and stomach adenocarcinoma. 25700553 LncRNADisease Lnc2Cancer